Severe Fever with Thrombocytopenia Syndrome Virus 3.0
A special issue of Viruses (ISSN 1999-4915). This special issue belongs to the section "Human Virology and Viral Diseases".
Deadline for manuscript submissions: closed (31 March 2024) | Viewed by 14826
Special Issue Editor
2. National Institute of Infectious Diseases, Tokyo, Japan
Interests: SFTS; SFTSV
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
We are still facing a global pandemic of COVID-19, originating from a novel coronavirus known as severe acute respiratory syndrome virus coronavirus 2 (SARS-CoV-2). In the period of 2013–2016, there was a huge outbreak of Ebola virus disease (EVD) in West Africa. Over the last 30 years, we have identified many novel infectious diseases with high case fatality rate which are caused by viruses and that spilled over from animals to humans. Severe fever with thrombocytopenia syndrome (SFTS) is one of the major emerging viral infections that must be included in this category.
SFTS was reported to be a novel bunyavirus infection by Chinese scientists as far back as 2011. SFTS is a tick-borne viral infection with high morbidity and mortality. SFTS was discovered to be endemic to Japan and South Korea in 2012. The case fatality rate in patients with SFTS in Japan is reported to be approximately 30%. The vectors which play a role in transmitting the causative agent, SFTS virus (SFTSV), are Haemaphysalis longicornis and others. Furthermore, patients with SFTS have been identified in Taiwan and Vietnam, indicating that the endemic area of SFTS is much wider than previously thought.
SFTSV is circulating in Asian countries including China, Korea, and Japan through the transmission of the virus between some species of ticks and mammals. The evidence indicates that SFTS has occurred in the past and will continue to occur in the future, suggesting we are unlikely to be able to escape from the risk being infected with SFTSV and that we are unable to eradicate this virus.
Ten years have passed since the discovery of SFTS. We have had some achievements in the elucidation of the SFTSV characteristics, clarification of the SFTS epidemiology, pathophysiology of SFTS in patients, mechanisms of SFTSV maintenance in nature, and in the development of specific treatments and vaccines. We aim to compile and present some recent research and achievements in minimizing the mortality and morbidity in patients with SFTS in this Special Issue. We welcome submissions addressing topics including, but not limited to the following:
- New topics in SFTSV virology;
- Epidemiology of SFTS;
- Clinical aspects and pathophysiology of SFTS in patients;
- Diagnostics of SFTS in humans and animals;
- SFTS as a zoonotic disease;
- Mechanisms of SFTSV maintenance in nature;
- Development of specific treatments for patients with SFTS;
- Development of vaccines against SFTS;
- Other topics specific to SFTS.
Dr. Masayuki Saijo
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Viruses is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.